News
Discover how digital innovation in clinical trial technology—eClinical platforms, remote data capture, and decentralized ...
As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and ...
AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...
Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...
Amycretin is a unimolecular long-acting GLP-1 and amylin receptor agonist under development by Novo Nordisk, to provide an ...
Our four modules (15 minutes a day) provide an introduction to the basics of clinical trial project management with skills, tools and local resources you can use immediately. Module 1: Project Manager ...
Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent ...
Phase 2 data expected in 2H 2026 - - KPL-387 Phase 1 single ascending dose data support profile for monthly dosing - LONDON, ...
Five deals that showcase the potential dealmakers see in the surgical equipment segment. Ampersand Capital, PAI Partners and Miura Partners are among the firms transacting; delving into a deal by LLR ...
Phase II CONFIDENCE study data reveal that simultaneous initiation of Kerendia and Jardiance significantly improves UACR and ...
An expert discusses how combining androgen receptor pathway inhibitors (ARPIs) with PARP inhibitors, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results